Department of Biological Sciences, Faculty of Science and Engineering, University of Limerick, V94 T9PX Limerick, Ireland.
Molecules. 2023 Jan 17;28(3):919. doi: 10.3390/molecules28030919.
Neuroinflammation is a hallmark of traumatic brain injury (TBI)'s acute and chronic phases. Despite the medical and scientific advances in recent years, there is still no effective treatment that mitigates the oxidative and inflammatory damage that affects neurons and glial cells. Therefore, searching for compounds with a broader spectrum of action that can regulate various inflammatory signaling pathways is of clinical interest. In this study, we determined not only the in vitro antioxidant capacity of apple pomace phenolics, namely, phlorizin and its metabolite, phloretin, but we also hypothesize that the use of these bioactive molecules may have potential use in TBI. We explored the antioxidant effects of both compounds in vitro (DPPH, iron-reducing capacity (IRC), and Folin-Ciocalteu reducing capacity (FCRC)), and using network pharmacology, we investigated the proteins involved in their protective effects in TBI. Our results showed that the antioxidant properties of phloretin were superior to those of phlorizin in the DPPH (12.95 vs. 3.52 mg ascorbic acid equivalent (AAE)/L), FCRC (86.73 vs. 73.69 mg gallic acid equivalent (GAE)/L), and iron-reducing capacity (1.15 vs. 0.88 mg GAE/L) assays. Next, we examined the molecular signature of both compounds and found 11 proteins in common to be regulated by them and involved in TBI. Meta-analysis and GO functional enrichment demonstrated their implication in matrix metalloproteinases, p53 signaling, and cell secretion/transport. Using MCODE and Pearson's correlation analysis, a subcluster was generated. We identified ESR1 (estrogen receptor alpha) as a critical cellular hub being regulated by both compounds and with potential therapeutic use in TBI. In conclusion, our study suggests that because of their vast antioxidant effects, probably acting on estrogen receptors, phloretin and phlorizin may be repurposed for TBI treatment due to their ease of obtaining and low cost.
神经炎症是创伤性脑损伤 (TBI) 急性和慢性阶段的一个标志。尽管近年来在医学和科学方面取得了进展,但仍然没有有效的治疗方法可以减轻影响神经元和神经胶质细胞的氧化和炎症损伤。因此,寻找具有更广泛作用谱的化合物来调节各种炎症信号通路具有临床意义。在这项研究中,我们不仅确定了苹果渣酚类化合物,即根皮苷及其代谢产物根皮素的体外抗氧化能力,而且还假设使用这些生物活性分子可能对 TBI 有潜在的用途。我们在体外研究了这两种化合物的抗氧化作用(DPPH、铁还原能力 (IRC) 和福林-酚还原能力 (FCRC)),并通过网络药理学研究了它们在 TBI 中保护作用所涉及的蛋白质。我们的结果表明,在 DPPH(12.95 与 3.52 毫克抗坏血酸当量 (AAE)/升)、FCRC(86.73 与 73.69 毫克没食子酸当量 (GAE)/升)和铁还原能力(1.15 与 0.88 毫克 GAE/L)测定中,根皮素的抗氧化性能优于根皮苷。接下来,我们检查了这两种化合物的分子特征,发现有 11 种共同调节的蛋白质与 TBI 有关。荟萃分析和 GO 功能富集表明,它们参与基质金属蛋白酶、p53 信号和细胞分泌/运输。使用 MCODE 和 Pearson 相关分析生成了一个子簇。我们确定 ESR1(雌激素受体 alpha)是一种关键的细胞枢纽,被这两种化合物调节,并且在 TBI 中具有潜在的治疗用途。总之,我们的研究表明,由于它们具有广泛的抗氧化作用,可能作用于雌激素受体,根皮苷和根皮素可能因其易于获得和低成本而被重新用于 TBI 治疗。